sambrinvest.be ↗Activity from announced rounds
Sambrinvest provides financing and company support in the Charleroi region, with activity across life sciences, digital businesses and industry.
Sambrinvest is a financial partner for businesses in the Charleroi region of Belgium. It supports entrepreneurs and small and medium-sized companies with financing adapted to their projects. Its work spans multiple sectors, including life sciences, technology and industrial businesses, and connects company funding with development of the regional business ecosystem.
RoundOS records Sambrinvest participation in Brenus Pharma, Enodia Therapeutics and Novadip Biosciences. Those financings cover cancer immunotherapy, protein-degradation drug discovery and regenerative medicine. They are examples within the database’s current coverage, while Sambrinvest maintains a much broader company portfolio.
A clinical-stage biotechnology company developing regenerative cell therapies and grafts to repair bone and other damaged tissues, including a pivotal-stage treatment for a rare pediatric bone disorder.
Develops an off-the-shelf in vivo immunotherapy platform for solid tumors
Develops small-molecule therapies for targeted protein degradation at the point of synthesis